Skip to main content
. 2020 Apr 28;77(20):4049–4067. doi: 10.1007/s00018-020-03525-8

Fig. 3.

Fig. 3

Log-rank test of continuous CREB1 expression as a prognostic marker for recurrence-free survival and overall survival. a Hazard ratio (HR) of overall survival from different cancer entities (pan cancer). b HR of overall survival from breast cancer and intrinsic subtypes. c HR of recurrence-free survival from breast cancer and intrinsic subtypes